Performance of the Cue COVID-19 point-of-care molecular test: insights from a multi-site clinic service model

The COVID-19 pandemic highlighted the critical need for rapid and accurate molecular diagnostic testing. The Cue COVID-19 Point-of-Care Test (Cue POCT) is a nucleic acid amplification test (NAAT), authorized by Health Canada and FDA as a POCT for SARS-CoV-2 detection. Cue POCT was deployed at a netw...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebbapragada, Anu, Cariazo, Lane, Elchuk, David, Abdelrahman, Hossam, Pham, Dang, Raveendraraj, Jerusha, Chokshi, Killol, Joseph, Nirochile, Gouzenkova, Elena, Gill, Harpreet, Blecher, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580901/
https://www.ncbi.nlm.nih.gov/pubmed/37728337
http://dx.doi.org/10.1128/spectrum.04064-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580901/
https://www.ncbi.nlm.nih.gov/pubmed/37728337
http://dx.doi.org/10.1128/spectrum.04064-22

Ejemplares similares